High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$992K
$992,586
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VERA
S
Vera Therapeutics, Inc.
Turner William D.
• Officer • Chief Regulatory Officer
Sell to Cover
2026-02-23
$91,819
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Regulatory Officer
Sell to Cover
|
2026-02-23 | $91,819 | S | Form 4 |
|
VERA
M
Vera Therapeutics, Inc.
Turner William D.
• Officer • Chief Regulatory Officer
Equity Compensation
2025-12-15
$155,300x2
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Regulatory Officer
Equity Compensation
|
2025-12-15 | $155,300x2 | M | Form 4 |
|
VERA
S
Vera Therapeutics, Inc.
Turner William D.
• Officer • Chief Regulatory Officer
10b5-1 SellΔOwn -30.8%
2025-12-15
$500,767
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Regulatory Officer
10b5-1 SellΔOwn -30.8%
|
2025-12-15 | $500,767 | S | Form 4 |
|
VERA
M
Vera Therapeutics, Inc.
Turner William D.
• Officer • Chief Regulatory Officer
Equity Compensation
2025-12-03
$155,300x2
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Regulatory Officer
Equity Compensation
|
2025-12-03 | $155,300x2 | M | Form 4 |
|
VERA
S
Vera Therapeutics, Inc.
Turner William D.
• Officer • Chief Regulatory Officer
10b5-1 SellΔOwn -30.8%
2025-12-03
$400,000
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Regulatory Officer
10b5-1 SellΔOwn -30.8%
|
2025-12-03 | $400,000 | S | Form 4 |